HCV core protein sequences
US7332269B2 · kind B2 · utility
1Cited by
5References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 10, 2002 |
| Grant date | Feb 19, 2008 |
| Priority date | — |
| Expiry date | Oct 10, 2022 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG06T7/277
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention describes peptides and recombinant proteins containing Hepatitis C virus core protein sequence in which one or more of the amino acids have been modified or deleted to remove the ability of these proteins to bind to specific anti-HCV murine monoclonal antibodies. The deletions and modifications are designed as to maintain the ability of this protein to be used in immunoassays used for the detection of anti-HCV antibodies in individuals infected with HCV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.